Heather Brechbuhl
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Estrogen | 5 | 2021 | 372 | 1.510 |
Why?
| Breast Neoplasms | 7 | 2021 | 1872 | 1.390 |
Why?
| Glutathione | 4 | 2011 | 303 | 0.980 |
Why?
| Naphthalenes | 4 | 2014 | 39 | 0.900 |
Why?
| Trachea | 3 | 2014 | 233 | 0.830 |
Why?
| Neoplastic Cells, Circulating | 1 | 2020 | 59 | 0.700 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2020 | 167 | 0.650 |
Why?
| ATP-Binding Cassette Transporters | 2 | 2010 | 123 | 0.650 |
Why?
| Biomarkers, Tumor | 3 | 2021 | 1048 | 0.620 |
Why?
| Neoplasm Metastasis | 1 | 2020 | 526 | 0.600 |
Why?
| Leukocytes, Mononuclear | 1 | 2020 | 501 | 0.590 |
Why?
| Receptor, ErbB-2 | 2 | 2020 | 302 | 0.560 |
Why?
| Cancer-Associated Fibroblasts | 1 | 2016 | 10 | 0.560 |
Why?
| Neoplasm Proteins | 2 | 2010 | 385 | 0.550 |
Why?
| CD146 Antigen | 3 | 2021 | 38 | 0.510 |
Why?
| Stem Cells | 3 | 2014 | 546 | 0.490 |
Why?
| Respiratory Mucosa | 3 | 2014 | 258 | 0.470 |
Why?
| src-Family Kinases | 1 | 2014 | 88 | 0.460 |
Why?
| Tumor Microenvironment | 4 | 2021 | 431 | 0.450 |
Why?
| Cell Lineage | 2 | 2011 | 310 | 0.410 |
Why?
| Cell Proliferation | 4 | 2017 | 2194 | 0.380 |
Why?
| Flavonoids | 1 | 2011 | 68 | 0.380 |
Why?
| Proto-Oncogene Proteins | 1 | 2014 | 609 | 0.370 |
Why?
| Antibiotics, Antineoplastic | 1 | 2011 | 114 | 0.370 |
Why?
| Carrier Proteins | 2 | 2014 | 701 | 0.350 |
Why?
| Doxorubicin | 1 | 2011 | 290 | 0.350 |
Why?
| MCF-7 Cells | 3 | 2020 | 105 | 0.350 |
Why?
| Prostaglandin D2 | 1 | 2009 | 21 | 0.340 |
Why?
| beta Catenin | 1 | 2011 | 220 | 0.330 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 1147 | 0.300 |
Why?
| Adenosine Triphosphate | 1 | 2010 | 431 | 0.300 |
Why?
| Receptors, Progesterone | 2 | 2020 | 319 | 0.280 |
Why?
| Tumor Cells, Cultured | 3 | 2020 | 850 | 0.280 |
Why?
| Estrogens | 3 | 2018 | 315 | 0.270 |
Why?
| Head and Neck Neoplasms | 1 | 2009 | 425 | 0.240 |
Why?
| Epithelial Cells | 3 | 2014 | 961 | 0.210 |
Why?
| Aromatase Inhibitors | 1 | 2021 | 49 | 0.200 |
Why?
| Cilia | 2 | 2014 | 162 | 0.200 |
Why?
| Cell Differentiation | 4 | 2014 | 1700 | 0.190 |
Why?
| Gene Expression Regulation | 1 | 2010 | 2353 | 0.180 |
Why?
| Cell Adhesion Molecules | 1 | 2021 | 168 | 0.180 |
Why?
| Estrogen Receptor alpha | 1 | 2021 | 120 | 0.180 |
Why?
| Antigens, Neoplasm | 1 | 2021 | 223 | 0.180 |
Why?
| Drug Resistance, Neoplasm | 2 | 2016 | 638 | 0.170 |
Why?
| Neoadjuvant Therapy | 1 | 2021 | 301 | 0.170 |
Why?
| Lung Neoplasms | 2 | 2011 | 2207 | 0.170 |
Why?
| Tamoxifen | 2 | 2018 | 192 | 0.170 |
Why?
| Neoplasm Invasiveness | 1 | 2020 | 445 | 0.160 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 49 | 0.150 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 746 | 0.150 |
Why?
| Humans | 15 | 2021 | 115587 | 0.150 |
Why?
| Mice, Transgenic | 2 | 2014 | 1970 | 0.150 |
Why?
| Female | 8 | 2021 | 59913 | 0.150 |
Why?
| RNA Polymerase III | 1 | 2017 | 25 | 0.150 |
Why?
| Polyadenylation | 1 | 2017 | 37 | 0.140 |
Why?
| Progestins | 1 | 2017 | 75 | 0.140 |
Why?
| ErbB Receptors | 1 | 2020 | 557 | 0.140 |
Why?
| Cell Line, Tumor | 4 | 2014 | 2751 | 0.140 |
Why?
| Carcinogenesis | 1 | 2017 | 178 | 0.130 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2016 | 139 | 0.130 |
Why?
| Mitochondrial Proteins | 1 | 2017 | 219 | 0.130 |
Why?
| Fibroblasts | 1 | 2020 | 839 | 0.130 |
Why?
| Tyrphostins | 1 | 2014 | 14 | 0.120 |
Why?
| Microtubule Proteins | 1 | 2014 | 15 | 0.120 |
Why?
| Benzothiazoles | 1 | 2014 | 33 | 0.120 |
Why?
| Regeneration | 2 | 2012 | 162 | 0.110 |
Why?
| Mice | 6 | 2018 | 15052 | 0.110 |
Why?
| Oxidative Stress | 2 | 2009 | 1093 | 0.110 |
Why?
| Quinazolines | 1 | 2014 | 241 | 0.110 |
Why?
| Prognosis | 1 | 2020 | 3339 | 0.100 |
Why?
| beta-Galactosidase | 1 | 2011 | 63 | 0.100 |
Why?
| Enzyme Inhibitors | 1 | 2014 | 757 | 0.090 |
Why?
| Keratin-14 | 1 | 2010 | 12 | 0.090 |
Why?
| Transgenes | 1 | 2011 | 169 | 0.090 |
Why?
| Chalcones | 1 | 2010 | 9 | 0.090 |
Why?
| Fluorescent Antibody Technique | 1 | 2011 | 398 | 0.090 |
Why?
| Nuclear Proteins | 1 | 2014 | 594 | 0.090 |
Why?
| Chelating Agents | 1 | 2009 | 71 | 0.090 |
Why?
| tert-Butylhydroperoxide | 1 | 2009 | 10 | 0.080 |
Why?
| Fungal Proteins | 1 | 2010 | 124 | 0.080 |
Why?
| Cytoprotection | 1 | 2009 | 53 | 0.080 |
Why?
| Gene Expression Profiling | 2 | 2017 | 1536 | 0.080 |
Why?
| Mitochondrial Diseases | 1 | 2009 | 77 | 0.080 |
Why?
| Biological Transport | 1 | 2010 | 375 | 0.080 |
Why?
| Organometallic Compounds | 1 | 2009 | 102 | 0.080 |
Why?
| Substrate Specificity | 1 | 2009 | 357 | 0.080 |
Why?
| Blotting, Western | 1 | 2011 | 1153 | 0.080 |
Why?
| Animals | 6 | 2018 | 32102 | 0.080 |
Why?
| Benzimidazoles | 1 | 2009 | 137 | 0.080 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2009 | 477 | 0.070 |
Why?
| Oxidation-Reduction | 1 | 2010 | 924 | 0.070 |
Why?
| Amino Acids | 1 | 2010 | 454 | 0.070 |
Why?
| Antioxidants | 1 | 2010 | 533 | 0.070 |
Why?
| Saccharomyces cerevisiae | 1 | 2010 | 482 | 0.070 |
Why?
| Obesity | 1 | 2018 | 2517 | 0.070 |
Why?
| Mice, Inbred C57BL | 2 | 2014 | 4773 | 0.060 |
Why?
| Models, Biological | 1 | 2010 | 1646 | 0.050 |
Why?
| Reactive Oxygen Species | 2 | 2017 | 549 | 0.050 |
Why?
| Biomarkers | 1 | 2011 | 3466 | 0.050 |
Why?
| Loss of Function Mutation | 1 | 2018 | 36 | 0.040 |
Why?
| 3' Untranslated Regions | 1 | 2017 | 136 | 0.040 |
Why?
| Mice, SCID | 1 | 2017 | 321 | 0.030 |
Why?
| Lymphatic Metastasis | 1 | 2017 | 276 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 621 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2017 | 560 | 0.030 |
Why?
| Weight Gain | 1 | 2018 | 453 | 0.030 |
Why?
| Signal Transduction | 2 | 2018 | 4541 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 704 | 0.030 |
Why?
| Homeodomain Proteins | 1 | 2018 | 465 | 0.030 |
Why?
| Basal Bodies | 1 | 2014 | 13 | 0.030 |
Why?
| Adipose Tissue | 1 | 2018 | 555 | 0.030 |
Why?
| Mucociliary Clearance | 1 | 2014 | 42 | 0.030 |
Why?
| Centrioles | 1 | 2014 | 35 | 0.030 |
Why?
| Amino Acid Motifs | 1 | 2014 | 198 | 0.030 |
Why?
| rab GTP-Binding Proteins | 1 | 2014 | 63 | 0.030 |
Why?
| Protein Transport | 1 | 2014 | 400 | 0.030 |
Why?
| RNA Interference | 1 | 2014 | 438 | 0.030 |
Why?
| RNA, Small Interfering | 1 | 2014 | 544 | 0.030 |
Why?
| HEK293 Cells | 1 | 2014 | 602 | 0.030 |
Why?
| Protein Structure, Tertiary | 1 | 2014 | 804 | 0.030 |
Why?
| Mitochondria | 1 | 2017 | 750 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 2418 | 0.020 |
Why?
| Diet | 1 | 2018 | 1072 | 0.020 |
Why?
| Cell Membrane | 1 | 2014 | 683 | 0.020 |
Why?
| Apoproteins | 1 | 2009 | 12 | 0.020 |
Why?
| Heme Oxygenase-1 | 1 | 2009 | 53 | 0.020 |
Why?
| Electron Transport | 1 | 2009 | 112 | 0.020 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 87 | 0.020 |
Why?
| Bronchi | 1 | 2010 | 250 | 0.020 |
Why?
| Copper | 1 | 2009 | 101 | 0.020 |
Why?
| Male | 1 | 2014 | 55949 | 0.020 |
Why?
| DNA, Mitochondrial | 1 | 2009 | 185 | 0.020 |
Why?
| Mice, Knockout | 1 | 2014 | 2604 | 0.020 |
Why?
| Apoptosis | 1 | 2017 | 2377 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2009 | 287 | 0.020 |
Why?
| Iron | 1 | 2009 | 235 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 930 | 0.020 |
Why?
| DNA Damage | 1 | 2009 | 357 | 0.020 |
Why?
| Cell Survival | 1 | 2009 | 1024 | 0.020 |
Why?
| Flow Cytometry | 1 | 2009 | 1083 | 0.020 |
Why?
| Cells, Cultured | 1 | 2010 | 3914 | 0.010 |
Why?
| Phenotype | 1 | 2010 | 2829 | 0.010 |
Why?
| Adult | 1 | 2017 | 30718 | 0.010 |
Why?
|
|
Brechbuhl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|